Track topics on Twitter Track topics that are important to you
Fifteen (15) healthy male volunteers will receive, following an overnight fasting and a standard breakfast, a single dose of either one of five different administrations.Subjects will undergo screening procedures within 21 days prior to first dosing. Eligible subjects will be admitted to the Clinical Research Center (CRC) in the evening before each study drug administration and will remain in-house for 24 hours after dosing. Following an overnight fast of at least 10 hours, the subjects will receive a standard meal within 30 minutes prior to dosing. Blood samples for PK will be drawn at specified time points. An End-of Study (EOS)/Safety Follow-up visit will take place on 7-10 days after the last dose of study treatment.
Fifteen (15) healthy male volunteers will receive, following an overnight fasting and a standard breakfast, a single dose of either one of five administrations: 3 soft capsules of PNL-THC:CBD, 2 soft capsules of P-PNL-THC:CBD, 1 hard capsule of CBD10, hard capsule of CBD100, Sativex® spray X 4 actuations. There will be a wash-out period of no less than 4 days between each dosing.
Subjects will undergo screening procedures within 21 days prior to first dosing, to assess their eligibility to participate in the study. Eligible subjects will be admitted to the Clinical Research Center (CRC) in the evening before each study drug administration and will remain in-house for 24 hours after dosing. Following an overnight fast of at least 10 hours, the subjects will receive a standard meal within 30 minutes prior to dosing. Blood samples for PK will be drawn at the specified time points. The subjects will be monitored for safety, and AEs will be recorded throughout the study. An End-of Study (EOS)/Safety Follow-up visit will take place on 7-10 days after the last dose of study treatment.
PNL-THC:CBD, Sativex, CBD
Clinical Research Center (CRC)- Souraskey Medical center
PhytoTech Therapeutics, Ltd.
Published on BioPortfolio: 2017-06-29T05:53:21-0400
To evaluate the effect of oral pH on the pharmacokinetics (PK) of a single oromucosal dose of Sativex (four sprays containing 10.8 mg Δ9 tetrahydrocannabinol (THC) and 10 mg cannabidiol (...
This is a six-month extension study to evaluate the safety of long-term Sativex® therapy when used as an adjunctive measure in patients with advanced cancer. The study provides continued ...
The purpose of this study is to determine whether Sativex® and GW-2000-02 are effective in the management of subjects with intractable cancer-related pain.
The purpose of this study is t to evaluate the efficacy, safety and tolerability of Sativex® in subjects diagnosed with MS and spasticity.
The purpose of this study is to assess the safety and tolerability of long term therapy with Sativex® and GW-2000-02.
The pharmacokinetics (PK) of β-lactam antibiotics in cystic fibrosis (CF) patients has been compared with that in healthy volunteers for over four decades; however, no quantitative models exist that ...
As with all early-stage testing of investigational drugs, clinical trials targeting HIV/AIDS can pose unknown risks to research subjects. Unlike sick participants seeking a therapeutic benefit, the mo...
Understanding the pharmacokinetics in cystic fibrosis (CF) patients is important for dosing. For antibiotics with extensive metabolism, however, a comparison of metabolite formation and elimination be...
There is limited research on healthy volunteers' perceptions of the risks of Phase I clinical trials. In order to contribute empirically to long-standing ethical concerns about healthy volunteers' inv...
To investigate differences in gait variability induced by two different single-dose opioid formulations and an inert placebo in healthy volunteers and knee osteoarthritis patients.
Persons with no known significant health problems who are recruited to participate in research to test a new drug, device, or intervention as controls for a patient group. (from http://clinicalcenter.nih.gov/recruit/volunteers.html, accessed 2/14/2013)
Hospital or other institutional ethics committees established to consider the ethical dimensions of patient care. Distinguish from ETHICS COMMITTEES, RESEARCH, which are established to monitor the welfare of patients or healthy volunteers participating in research studies.
Human experimentation that is not intended to benefit the subjects on whom it is performed. Phase I drug studies (CLINICAL TRIALS, PHASE I AS TOPIC) and research involving healthy volunteers are examples of nontherapeutic human experimentation.
Healthy People Programs are a set of health objectives to be used by governments, communities, professional organizations, and others to help develop programs to improve health. It builds on initiatives pursued over the past two decades beginning with the 1979 Surgeon General's Report, Healthy People, Healthy People 2000: National Health Promotion and Disease Prevention Objectives, and Healthy People 2010. These established national health objectives and served as the basis for the development of state and community plans. These are administered by the Office of Disease Prevention and Health Promotion (ODPHP). Similar programs are conducted by other national governments.
Governmental guidelines and objectives pertaining to public food supply and nutrition including recommendations for healthy diet and changes in food habits to ensure healthy diet.
Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...